UTHR (United Therapeutics) Days Payable : 7.21 (As of Dec. 2024)

View and export this data going back to 1999. Start your Free Trial

What is United Therapeutics Days Payable?

United Therapeutics's average Accounts Payable for the three months ended in Dec. 2024 was $6 Mil. United Therapeutics's Cost of Goods Sold for the three months ended in Dec. 2024 was $76 Mil. Hence, United Therapeutics's Days Payable for the three months ended in Dec. 2024 was 7.21.

The historical rank and industry rank for United Therapeutics's Days Payable or its related term are showing as below:

UTHR' s Days Payable Range Over the Past 10 Years
Min: 6.84 Med: 26.07 Max: 51.21
Current: 6.84

During the past 13 years, United Therapeutics's highest Days Payable was 51.21. The lowest was 6.84. And the median was 26.07.

UTHR's Days Payable is ranked worse than
99.15% of 946 companies
in the Drug Manufacturers industry
Industry Median: 85.85 vs UTHR: 6.84

United Therapeutics's Days Payable increased from Dec. 2023 (7.20) to Dec. 2024 (7.21). It may suggest that United Therapeutics delayed paying its suppliers.

United Therapeutics Days Payable Historical Data

The historical data trend for United Therapeutics's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

United Therapeutics Days Payable Chart

United Therapeutics Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Days Payable

Get a 7-Day Free Trial

23.64

11.77

9.51

6.87

6.84

United Therapeutics Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Days Payable	Get a 7-Day Free Trial															7.20	7.01	-	-	7.21

Competitive Comparison of United Therapeutics's Days Payable

For the Drug Manufacturers - Specialty & Generic subindustry, United Therapeutics's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

United Therapeutics's Days Payable Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, United Therapeutics's Days Payable distribution charts can be found below:

* The bar in red indicates where United Therapeutics's Days Payable falls into.

Save Embed

;

Save Embed

;

United Therapeutics Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

United Therapeutics's Days Payable for the fiscal year that ended in Dec. 2024 is calculated as

	Days Payable (A: Dec. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2023 )	+	Accounts Payable (A: Dec. 2024 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2024 )	*	Days in Period
=	( (5.6	+	6)	/	2 )	/	309.7	*	365
=	5.8					/	309.7	*	365
=	6.84

United Therapeutics's Days Payable for the quarter that ended in Dec. 2024 is calculated as:

	Days Payable (Q: Dec. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Sep. 2024 )	+	Accounts Payable (Q: Dec. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2024 )	*	Days in Period
=	( (0	+	6)	/	1 )	/	75.9	*	365 / 4
=	6					/	75.9	*	365 / 4
=	7.21

United Therapeutics Days Payable Related Terms

Thank you for viewing the detailed overview of United Therapeutics's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

United Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » United Therapeutics Corp (NAS:UTHR) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

UTH:Germany UTH:Germany U2TH34:Brazil

Address

1000 Spring Street, Silver Spring, MD, USA, 20910

Website

https://www.unither.com

United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. In addition, it is developing a pipeline of projects that includes new indications and delivery devices for existing products and new products to treat PAH and other conditions.

Executives

Christopher Patusky	director
Michael Benkowitz	officer: President and COO	C/O UNITED THERAPEUTICS CORP, 1040 SPRING STREET, SILVER SPRING MD 20910
Tommy G Thompson	director	7711 CARONDELET, ST. LOUIS MO 63105
Ray Kurzweil	director
Nilda Mesa	director	C/O UNITED THERAPEUTICS CORPORATION, 1040 SPRING STREET, SILVER SPRING MD 20910
Louis W Sullivan	director
Paul A Mahon	officer: EVP & General Counsel
Judy D. Olian	director	2000 AVENUE OF THE STARS 12TH FL, LOS ANGELES CA 90067
Richard Giltner	director	C/O UNITED THERAPEUTICS CORPORTION, 1735 CONNECTICUT AVE. NW, WASHINGTON DC 20009
James Edgemond	officer: CFO and Treasurer	1040 SPRING STREET, SILVER SPRING MD 20910
Christopher Causey	director
Martine A Rothblatt	director, officer: Chief Executive Officer
Raymond Dwek	director
Linda Maxwell	director	1040 SPRING STREET, SILVER SPRING NC 27709
Katherine J Klein	director	STEINBERG HALL-DIETRICH HALL, 3620 LOCUST WALK, PHILADELPHIA PA 19104